Tzehoval E - Search Results

1

On the development of a neoantigen vaccine for the prevention of Lynch Syndrome.

Solomon A, Alteber Z, Bassan D, Sharbi-Yunger A, Esbit S, Tzehoval E, Eisenbach L. Solomon A, et al. Among authors: tzehoval e. Int J Cancer. 2022 Jul 1;151(1):107-119. doi: 10.1002/ijc.33971. Epub 2022 Mar 25. Int J Cancer. 2022. PMID: 35179790

2

A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival.

Sharbi-Yunger A, Grees M, Cafri G, Bassan D, Eichmüller SB, Tzehoval E, Utikal J, Umansky V, Eisenbach L. Sharbi-Yunger A, et al. Among authors: tzehoval e. Int J Cancer. 2019 Feb 15;144(4):909-921. doi: 10.1002/ijc.31795. Epub 2018 Dec 5. Int J Cancer. 2019. PMID: 30106470

3

Optimizing T-cell receptor avidity with somatic hypermutation.

Bassan D, Gozlan YM, Sharbi-Yunger A, Tzehoval E, Eisenbach L. Bassan D, et al. Among authors: tzehoval e. Int J Cancer. 2019 Nov 15;145(10):2816-2826. doi: 10.1002/ijc.32612. Epub 2019 Aug 24. Int J Cancer. 2019. PMID: 31381134

4

Exuberated numbers of tumor-specific T cells result in tumor escape.

Goldberger O, Volovitz I, Machlenkin A, Vadai E, Tzehoval E, Eisenbach L. Goldberger O, et al. Among authors: tzehoval e. Cancer Res. 2008 May 1;68(9):3450-7. doi: 10.1158/0008-5472.CAN-07-5006. Cancer Res. 2008. PMID: 18451173

5

The human 1-8D gene (IFITM2) is a novel p53 independent pro-apoptotic gene.

Daniel-Carmi V, Makovitzki-Avraham E, Reuven EM, Goldstein I, Zilkha N, Rotter V, Tzehoval E, Eisenbach L. Daniel-Carmi V, et al. Among authors: tzehoval e. Int J Cancer. 2009 Dec 15;125(12):2810-9. doi: 10.1002/ijc.24669. Int J Cancer. 2009. PMID: 19544527

6

Production of LacZ inducible T cell hybridoma specific for human and mouse gp100₂₅₋₃₃ peptides.

Cafri G, Sharbi-Yunger A, Tzehoval E, Eisenbach L. Cafri G, et al. Among authors: tzehoval e. PLoS One. 2013;8(2):e55583. doi: 10.1371/journal.pone.0055583. Epub 2013 Feb 1. PLoS One. 2013. PMID: 23383339 Free PMC article.

7

Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity.

Alteber Z, Azulay M, Cafri G, Vadai E, Tzehoval E, Eisenbach L. Alteber Z, et al. Among authors: tzehoval e. Cancer Immunol Immunother. 2014 Apr;63(4):369-80. doi: 10.1007/s00262-014-1520-4. Epub 2014 Jan 23. Cancer Immunol Immunother. 2014. PMID: 24452202 Free PMC article.

8

mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity.

Cafri G, Sharbi-Yunger A, Tzehoval E, Alteber Z, Gross T, Vadai E, Margalit A, Gross G, Eisenbach L. Cafri G, et al. Among authors: tzehoval e. Mol Ther. 2015 Aug;23(8):1391-1400. doi: 10.1038/mt.2015.90. Epub 2015 May 22. Mol Ther. 2015. PMID: 25997427 Free PMC article.

9

The anti-inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiota.

Alteber Z, Sharbi-Yunger A, Pevsner-Fischer M, Blat D, Roitman L, Tzehoval E, Elinav E, Eisenbach L. Alteber Z, et al. Among authors: tzehoval e. Immunol Cell Biol. 2018 Mar;96(3):284-297. doi: 10.1111/imcb.12000. Epub 2018 Jan 22. Immunol Cell Biol. 2018. PMID: 29356071

10

Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.

Porgador A, Tzehoval E, Vadai E, Feldman M, Eisenbach L. Porgador A, et al. Among authors: tzehoval e. Cancer Res. 1995 Nov 1;55(21):4941-9. Cancer Res. 1995. PMID: 7585534

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters